Bee Venom Activates the Nrf2/HO-1 and TrkB/CREB/BDNF Pathways in Neuronal Cell Responses against Oxidative Stress Induced by Aβ1–42
Open Access
- 21 January 2022
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (3) , 1193
Abstract
Honeybee venom has recently been considered an anti-neurodegenerative agent, primarily due to its anti-inflammatory effects. The natural accumulation of amyloid-beta (Aβ) in the brain is reported to be the natural cause of aging neural ability downfall, and oxidative stress is the main route by which Aβ ignites its neural toxicity. Anti-neural oxidative stress is considered an effective approach for neurodegenerative therapy. To date, it is unclear how bee venom ameliorates neuronal cells in oxidative stress induced by Aβ. Here, we evaluated the neuroprotective effect of bee venom on Aβ-induced neural oxidative stress in both HT22 cells and an animal model. Our results indicate that bee venom protected HT22 cells against apoptosis induced by Aβ1–42. This protective effect was explained by the increased nuclear translocation of nuclear factor erythroid 2-like 2 (Nrf2), consequently upregulating the production of heme oxygenase-1 (HO-1), a critical cellular instinct antioxidant enzyme that neutralizes excessive oxidative stress. Furthermore, bee venom treatment activated the tropomyosin-related kinase receptor B (TrkB)/cAMP response element-binding (CREB)/brain-derived neurotrophic factor (BDNF), which is closely related to the promotion of cellular antioxidant defense and neuronal functions. A mouse model with cognitive deficits induced by Aβ1–42 intracerebroventricular (ICV) injections was also used. Bee venom enhanced animal cognitive ability and enhanced neural cell genesis in the hippocampal dentate gyrus region in a dose-dependent manner. Further analysis of animal brain tissue and serum confirmed that bee venom reduced oxidative stress, cholinergic system activity, and intercellular neurotrophic factor regulation, which were all adversely affected by Aβ1–42. Our study demonstrates that bee venom exerts antioxidant and neuroprotective actions against neural oxidative stress caused by Aβ1–42, thereby promoting its use as a therapeutic agent for neurodegenerative disorders.Keywords
Funding Information
- National Research Foundation of Korea (NRF-2019R1G1A1100651 and NRF-2021R1A2C2007041)
This publication has 71 references indexed in Scilit:
- Differences in the origin of philosophy between Chinese medicine and western medicine: Exploration of the holistic advantages of Chinese medicineChinese Journal of Integrative Medicine, 2013
- Schizandrin, an Antioxidant Lignan fromSchisandra chinensis,Ameliorates Aβ1–42-Induced Memory Impairment in MiceOxidative Medicine and Cellular Longevity, 2012
- Butyrylcholinesterase inhibitors ameliorate cognitive dysfunction induced by amyloid-β peptide in miceBehavioural Brain Research, 2011
- Role of CREB in the regulatory action of sarsasapogenin on muscarinic M1receptor density during cell agingFEBS Letters, 2010
- OnTrk—The TrkB Signal Transduction Pathway Is an Increasingly Important Target in Cancer BiologyClinical Cancer Research, 2009
- Expression of Nrf2 in Neurodegenerative DiseasesJournal of Neuropathology & Experimental Neurology, 2007
- Morris water maze: procedures for assessing spatial and related forms of learning and memoryNature Protocols, 2006
- Protective effects of compound FLZ on beta-amyloid peptide-(25-35)-induced mouse hippocampal injury and learning and memory impairment1Acta Pharmacologica Sinica, 2006
- Nitric oxide in brain: diffusion, targets and concentration dynamics in hippocampal subregionsMolecular Aspects of Medicine, 2004
- Amyloidosis and Alzheimer’s diseaseAdvanced Drug Delivery Reviews, 2002